Amedisys, Inc. Profile Avatar - Palmy Investing

Amedisys, Inc.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the ho…
Medical - Care Facilities
US, Baton Rouge [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
52.13 49.80 46.79 43.47 42.53 42.63 43.31 42.05 41.27 40.28 41.18 42.78 44.30 43.31 20.44
Profit Margin
8.98 6.89 -26.01 -5.62 -7.70 1.06 -0.24 2.59 1.98 7.18 6.49 8.86 9.44 5.34 -0.44
Operating Margin
15.25 11.84 -32.02 -7.54 -12.40 2.00 -0.72 3.99 5.12 9.33 9.07 10.58 11.38 8.13 8.63
EPS Growth
52.13 -19.44 -431.59 79.00 -10.00 112.66 -123.46 1,324.04 -19.64 304.44 8.52 42.79 13.65 -43.06 -108.22
Return on Assets (ROA)
11.59 8.66 -44.56 -11.44 -13.24 1.91 -0.44 5.08 3.72 16.64 10.04 11.72 11.26 6.00 -0.47
Return on Equity (ROE)
18.48 12.82 -73.71 -18.48 -25.84 3.22 -0.74 8.10 5.88 24.78 19.80 22.69 22.45 11.28 -0.91
Return on Invested Capital (ROIC)
14.87 11.15 -55.57 -16.54 -22.72 2.97 -13.50 6.34 4.94 23.97 13.78 17.25 12.79 8.35 -3.61
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
18.35 13.99 16.95 14.22 6.71 17.38 14.60 12.67 10.92 1.03 25.82 19.59 29.38 27.22 19.87
Debt/Equity
29.27 20.72 28.03 22.97 13.09 29.30 24.42 20.22 17.24 1.53 50.91 37.94 58.58 51.16 38.38
Debt/EBITDA
69.06 26.59 -22.68 93.45 65.68 178.76 67.27 69.17 1.86 -7.15 122.87 76.62 152.44 193.96 157.37
Debt/Capitalization
22.64 17.16 21.89 18.68 11.57 22.66 19.62 16.82 14.70 1.51 33.74 27.51 36.94 33.84 27.74
Interest Debt per Share USD
8.33 6.82 5.38 3.88 1.70 3.86 3.36 2.96 2.79 0.45 10.60 9.77 17.01 17.23 13.52
Debt Growth
-34.52 -15.47 -20.03 -28.55 -53.13 138.94 -14.07 -6.97 -4.50 -91.69 4,314.24 -5.84 77.70 -1.41 -9.43
Liquidity
Current Ratio
95.09 135.89 104.64 100.49 65.71 83.51 100.04 118.51 144.68 100.74 107.22 79.32 95.30 109.40 104.90
Quick Ratio
80.57 121.05 88.42 91.08 43.80 66.14 87.05 108.22 133.71 94.03 81.94 73.84 84.87 94.88 100.07
Cash Ratio
15.04 55.61 21.65 7.10 5.54 4.95 15.70 16.65 40.16 9.09 9.27 17.93 11.41 11.40 30.79
Operating Cash Flow Ratio
100 - - - - - - - - - - - - - - - - 100 - - - - - - - - - -
Turnover
Inventory Turnover
7,048.01 8,248.32 6,910.59 7,912.20 1,086.92 8,136.83 8,950.86 11,262.07 12,289.89 13,119.23 1,545.34 10,074.53 9,182.91 4,997.52 - -
Receivables Turnover
1,007.17 1,154.60 993.08 865.20 1,045.19 1,212.74 1,024.35 865.64 762.28 879.80 823.09 811.90 805.25 749.09 681.46
Payables Turnover
4,381.40 3,510.14 3,071.04 2,883.11 3,565.20 4,304.07 2,826.55 2,744.10 3,548.40 3,479.95 3,680.02 2,777.73 3,227.24 2,881.96 6,301.33
Asset Turnover
129.10 125.73 171.31 203.66 171.99 179.85 186.92 195.83 188.53 231.84 154.87 132.18 119.23 112.50 108.55
Coverage
Interest Coverage
1,977.28 2,103.14 -5,337.41 -922.06 -3,512.49 292.65 -85.00 1,110.38 1,560.80 2,105.13 1,222.68 1,986.48 2,644.78 813.26 617.34
Asset Coverage
400 500 400 400 800 400 400 500 600 6,100 200 300 200 200 300
Cash Flow Coverage (CFGR)
115.11 113.42 97.40 66.88 209.97 -56.31 107.78 66.92 119.01 3,025.36 61.95 94.11 34.62 24.78 33.51
EBITDA Coverage
2,200 2,500 -4,800 700 1,000 700 900 1,700 2,600 2,400 1,600 2,600 3,400 1,100 600
Dividend Coverage
- - -37,000 - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 - - 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
- - 0.03 - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
10.26 11.99 -122.18 -24.73 -21.04 1.35 -0.23 2.63 1.71 3.11 2.36 1.92 3.96 4.37 -0.32
Price/Earnings (P/E)
974.28 834.14 -81.85 -404.40 -475.25 7,420.43 -42,974.77 3,798.16 5,862.97 3,217.66 4,230.08 5,201.59 2,527.40 2,290.27 -31,792.97
Price/Book (P/B)
180.02 106.97 60.33 74.73 122.81 238.70 316.98 307.52 344.74 797.40 837.71 1,180.21 567.36 258.32 290.56
Price/Sales (P/S)
87.44 57.46 21.29 22.72 36.59 78.70 101.38 98.45 115.83 230.98 274.34 461.04 238.65 122.19 138.57
Price/Cash Flow (P/CF)
534.37 455.26 220.98 486.41 446.97 -1,446.63 1,204.50 2,273.13 1,680.24 1,718.32 2,656.01 3,305.23 2,797.40 2,038.12 2,258.84
End of AMED's Analysis
CIK: 896262 CUSIP: 023436108 ISIN: US0234361089 LEI: - UEI: -
Secondary Listings
AMED has no secondary listings inside our databases.